These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 10388118)
1. The Goal of Cancer Treatment. Balis FM Oncologist; 1998; 3(4):V. PubMed ID: 10388118 [TBL] [Abstract][Full Text] [Related]
2. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
3. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
4. Cancer Drug Development: New Targets for Cancer Treatment. Curt GA Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. The Cure for Cancer: Not If but When. Black KL Oncologist; 1997; 2(5):IX-X. PubMed ID: 10388068 [TBL] [Abstract][Full Text] [Related]
7. Modeling growth kinetics and statistical distribution of oligometastases. Withers HR; Lee SP Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446 [TBL] [Abstract][Full Text] [Related]
8. Implications of the new biology for therapy in breast cancer. Sledge GW Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850 [TBL] [Abstract][Full Text] [Related]
9. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided? Schlag PM Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128 [TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
11. [History and significance of sensitivity test of anticancer drugs]. Taguchi T Gan To Kagaku Ryoho; 1982 Apr; 9(4):570-4. PubMed ID: 7184413 [TBL] [Abstract][Full Text] [Related]
12. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Poste G Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734 [TBL] [Abstract][Full Text] [Related]
15. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research. Sarlis NJ Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792 [TBL] [Abstract][Full Text] [Related]
16. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Zucker S; Cao J; Chen WT Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650 [TBL] [Abstract][Full Text] [Related]
17. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for breast cancer. Hennessy BT; Pusztai L Minerva Ginecol; 2005 Jun; 57(3):305-26. PubMed ID: 16166938 [TBL] [Abstract][Full Text] [Related]